Home › Funds › ADAR1 Capital Management, LLC › ABCL
ADAR1 Capital Management, LLC position in ABCL
ABCELLERA BIOLOGICS INC · Health Care
ADAR1 Capital Management, LLC reported holding 822,163 shares of ABCL (ABCELLERA BIOLOGICS INC) in its Q3 2026 13F filing — a position valued at US$12.0M, representing 0.66% of its reported portfolio and ranking #40 among its reported holdings. ADAR1 Capital Management, LLC has disclosed ABCL holdings in 3 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How ADAR1 Capital Management, LLC's ABCL position evolved
ADAR1 Capital Management, LLC first disclosed a stake in ABCL in Q3 2024 at 114,981 shares (US$299K). The position peaked in Q3 2026 at 822,163 shares, worth US$12.0M. Across 3 filings, ADAR1 Capital Management, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 822,163 shares valued at US$12.0M. Notable position changes include a 87% trim in Q4 2024 (shares fell 24% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 114.98K | $298.95K | New |
| Q4 2024 | 14.98K | $43.89K | Reduce |
| Q3 2026 | 822.16K | $12.00M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABCL and 13F data
ABCL (ABCELLERA BIOLOGICS INC) is a Health Care company. 46 other funds we track also report a position in ABCL — the largest reported positions include BAKER BROS. ADVISORS LP (US$259.1M), ArrowMark Colorado Holdings LLC (US$70.4M), Guardian Partners Inc. (US$8.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABCL
- BAKER BROS. ADVISORS LP 33.01M sh · $259.15M · Q2 2026
- ArrowMark Colorado Holdings LLC 4.82M sh · $70.37M · Q3 2026
- Guardian Partners Inc. 596.00K sh · $8.70M · Q3 2026
- Intellectus Partners, LLC 584.13K sh · $8.52M · Q3 2026
- Informed Momentum Co LLC 446.19K sh · $6.51M · Q3 2026
- Global IMC LLC 278.90K sh · $4.07M · Q3 2026
- SOFTBANK GROUP CORP. 172.58K sh · $2.52M · Q3 2026
More on ADAR1 Capital Management, LLC
FAQ
How long has ADAR1 Capital Management, LLC held ABCL?
ADAR1 Capital Management, LLC has disclosed ABCL holdings in 3 of the last 9 reported quarters, going back to Q3 2024.
What is ADAR1 Capital Management, LLC's current position in ABCL?
As of Q3 2026, ADAR1 Capital Management, LLC holds 822.16K shares of ABCL (ABCELLERA BIOLOGICS INC), valued at $12.00M, representing 0.66% of its reported portfolio and ranking #40.
Has ADAR1 Capital Management, LLC been buying or selling ABCL?
In the latest 13F filing (Q3 2026), ADAR1 Capital Management, LLC newly opened its position in ABCL. The position peaked in Q3 2026 at 822.16K shares.
Which other funds hold ABCL?
Other major institutional holders of ABCL include BAKER BROS. ADVISORS LP, ArrowMark Colorado Holdings LLC, Guardian Partners Inc., among 46 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.